Fistulising Crohn's disease - continuing authority application form (PB093)

Use this form to apply to continue PBS-subsidised treatment with a biological medicine for complex refractory fistulising Crohn's disease.

Biological medicine refers to adalimumab, infliximab and ustekinumab.

Please note: You don’t need to complete this form if you use the Online PBS Authorities system.

Download and complete the fistulising Crohn’s disease - continuing authority application form.

Page last updated: 1 December 2025.
QC 20776